PEGylated nanostructured lipid carriers loaded with 10-hydroxycamptothecin: An efficient carrier with enhanced anti-tumour effects against lung cancer

Journal of Pharmacy and Pharmacology

Volumn 60, Issue 8, 2008, Pages 1077-1087

  Zhang, Xinxin ^a,b   Gan, Yong ^b   Gan, Li ^b   Nie, Shufang ^a   Pan, Weisan ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

10 HYDROXYCAMPTOTHECIN; SOLID LIPID NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG STABILITY; DRUG STRUCTURE; DRUG UPTAKE; ENCAPSULATION; FEMALE; FLUORESCENCE MICROSCOPY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; LUNG CANCER; MEAN RESIDENCE TIME; MOUSE; NONHUMAN; PARTICLE SIZE; SINGLE DRUG DOSE; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CAMPTOTHECIN; CELL LINE, TUMOR; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRUG COMPOUNDING; DRUG STABILITY; FEMALE; HUMANS; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, NUDE; MOLECULAR WEIGHT; NANOSTRUCTURES; PARTICLE SIZE; POLYETHYLENE GLYCOLS; SOLUBILITY; STEARATES; TISSUE DISTRIBUTION;

EID: 47949130908     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.60.8.0014     Document Type: Article

References (36)

1. Alexander, V. K. (2006) Polymer genomics: An insight into pharmacology and toxicology of nanomedicines. Adv. Drug Deliv. Rev. 58: 1597-1621
2. Bazile, D., Prud'Homme, C., Bassoullet, M. T., Marlard, M., Spenlehauer, H., Veillard, M. (1995) Stealth MePEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system. J. Pharm. Sci. 84: 493-498
3. Cortesi, R., Esposito, E., Maietti, A., Menegatti, E., Nastruzzi, C. (1997) Formulation study for the antitumor drug campothecin: liposomes, micellar solutions and a miroemulsion. Int. J. Pharm. 308: 183-189
4. Desai, M. P., Labhasetwar, V., Walter, E., Levy, R. J., Amidon, G. L. (1997) The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent. Pharm. Res. 14: 1568-1573
5. Dziubla, T., Muzukantov, V. (2006) Nanocarriers for the vascular delivery of drugs to the lungs. In: Torchilin, V. P. (ed) Nanoparticulates as drug carriers. Imperial College Press, London, pp 499-526
6. Evangelos, C. G., Maria, H., Evangelia, P., Konstantinos, A. (2007) Anticancer activity of cisplatin-loaded PLGA-mPEG nanoparticles on LNCaP prostate cancer cells. Eur. J. Pharm. Biopharm. 67: 1-8
7. Hawley, A. E., Ilium, L., Davis, S. S. (1997) Preparation of biodegradable, surface engineered PLGA nanospheres with enhanced lymphatic drainage and lymph node uptake. Pharm. Res. 14: 657-661
8. Hu, F. Q., Jiang, S. P., Du, Y. Z., Yuan, H., Ye, Y. Q., Zeng, S. (2005) Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system. Colloid Surface B: Biointerfaces 45: 167-173
9. Igor, C., Jean, M. M., Ganesh, D. S., Jean, F. R., Michel, M. (1998) Kinetics of lactone hydrolysis in antitumor drugs of camptothecin series as studied by fluorescence spectroscopy. Biochim. Biophys. Acta. 1379: 353-366
10. Inaba, M. (1994) Kinetic analysis of cell-killing action of DNA topoisomerase I and II inhibitors, Abstract of Research Works for the General Research A of Subject Number 05302061 with a Grants-in-Aid for Scientific Research from the Ministry of Education. Science, Sports and Culture of Japan. 57-61
11. Jaxel, C., Kohn, K. W., Wani, M. C., Wall, M. E. Pommier, Y. (1989) Structure-activity study of the actions of camptothecin derivatives on mammalian topoisomerase I: Evidence for a specific receptor site and for a relation to antitumour activity. Cancer Res. 49: 1465-1469
12. Jeon, S. I., Andrade, J. D. (1991) Protein-surface interactions in the presence or polyethylene oxide: II Effect of protein size. J. Colloid Interf Sci. 142: 159-166
13. Jeon, S. I., Lee, J. H., Andrade, J. D., Gennes, P. G. (1991) Protein-surface interactions in the presence of polyethylene oxide: I Simplified theory. J. Colloid Interf. Sci. 142: 149-158
14. Jung, T., Kamm, W., Breitenbach, A., Kaiserling, E., Xiao, J. X., Kissel, T. (2000) Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake. Eur. J. Pharm. Biopharm. 50: 147-160
15. Leyang, Z., Mi, Y., Qin, W., Yuan, L., Rui, G., Xiqun, J., Changzheng, Y., Baorui, L. (2007) 10-Hydroxycamptothecin loaded nanoparticles: preparation and antitumor activity in mice, J. Control Release 119: 153-162
16. Lorenze, M. R., Holzapfel, V., Musyanovych, A., Nothelfer, K., Walther, P., Frank, H., Landfester, K., Schrezenmeier, H., Mailandr, V. (2006) Uptake of functionalized, fluorescent-labeled polymeric particles in different cell lines and stem cells. Biomaterials 27: 2820-2828
17. Maeda, H., Wu, J., Sawa, T., Matsumura, Y., Hori, K. (2000) Tumor vascular permeability and the EPR effect in maromolecular therapeutics: a review. J. Control. Release 65: 271-284
18. Maeda, H., Fang, J., Inutsuka, T., Kitamoto, Y. (2003) Vascular permeability enhancement in solid tumor: various factors, mechanisms involved and its implications. Int Immunopharmacol. 3: 319-328
19. Mi, Z., Burke, T. G. (1994) Differential interactions of camptothecin lactone and carboxylate forms with human blood components. Biochemistry 33: 10325-10336
20. Michalowski, C. B., Guterres, S. S., Dalla Costa, T. (2004) Microdialysis for evaluating the entrapment and release of a lipophilic drug from nanoparticles. J. Pharmceut. Biomed. 35: 1093-1100
21. Moghimi, S. M., Hunter, A. C., Murray, J. C. (2001) Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol. Rev. 53: 283-318
22. Müller, R. H., Radtke, M., Wissing, S. A. (2002) Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLCs) in cosmetic and dermatological preparations. Adv. Drug Deliv. Rev. 54 (Suppl. 1): S131-S155
23. O'Leary, J., Muggia, F. M. (1998) Camptothecins: a review of their development and schedules of administration. Eur. J. Cancer 34: 1500-1508
24. O'Reilly, S. O., Rowinsky, E. K., Slichenmyer, W., Donehower, R. C., Forastiere, A. A., Ettinger, D. S., Chen, T. L., Sartorius, S., Grochow, L. B. (1996) Phase I and pharmacologic study of topotecan in patients with impaired renal function. J. Clin. Oncol. 14: 3062-3073
25. Peracchia, M. T., Vauthier, C., Passirani, C., Couvreur, P., Labrre, D. (1997) Complement consumption by poly(ethylene glycol) in different conformations chemically coupled to poly(isobutyl 2-cyanoacrylate) nanoparticles. Life Sci. 61: 749-761
26. Qingyu, X., Minting, W., Fu, C., Tao, G., Yanlin, J., Zhirong, Z., Yuan, H. (2007) Lung-targeting delivery of dexamethasone acetate loaded solid lipid nanoparticles. Arch. Pharm. Res. 40: 519-525
27. Sadzuka, Y., Hirota, S. (1997) Physical properties and tissue distribution of adriamycin encapsulated in polyethyleneglycol-coated liposomes. Adv. Drug Deliv. Rev. 24: 257-263
28. Serrano, A. G., Perez-Gil, J. (2006) Protein-lipid interactions and surface activity in the pulmonary surfactant system. Chem. Phys. Lipids. 141: 105-118
29. Shimada, K., Miyagishima, A., Sadzuka, Y., Nozawa, Y., Mochizuki, Y., Ohshima, H., Hirota, S. (1995) Determination of the thickness of the fixed aqueous layer around polyethyleneglycol-coated liposomes. J. Drug Target. 3: 283-289
30. Sims, G.E., Snape, T. J. (1980) A method for the estimation of polyethylene glycol in plasma protein fractions. Anal. Biochem. 107: 60-63
31. Wani, M. C., Ronman, P. E., Lindley, J. T., Wall, M. E. (1980) Plant antitumor agents. 18. Synthesis and biological activity of camptothecin analogues. J. Med. Chem. 3: 554-560
32. Williams, J., Lansdown, R., Sweitzer, R., Romanowski, M., LaBell, R., Ramaswami, R., Unger, E. (2003) Nanoparticle drug delivery system for intravenous delivery of topoisomerase inhibitors. J Control Release 91: 167-172
33. Yasuyuki, S., Akiko, N., Rieko, H., Atsuo, M., Yasuo, N., Sadao, H., Takashi, S. (2002) Effects of mixed polyethyleneglycol modification on fixed aqueous layer thickness and antitumor activity of doxorubicin containing liposome. Int. J. Pharm. 238: 171-180
34. Zauner, W., Farrow, N. A., Hainess, A. M. R. (2001) In vitro uptake of polystyrene microspheres: effect of particle size, cell line and cell density. J. Control. Release 71: 39-51
35. Zerrin, S., Nilufer, Y., Tamer, B. (2006) Preparation and characterization of polymeric micelles for solubilization of poorly soluble anticancer drugs. Eur. J. Pharm. Biopharm. 64: 261-268
36. Zhou, J., Fan, Y. J., Chen, D. N., Liang, Z., Yang, W. L. (1991) An experimental evaluation of the antitumor activity and toxicity of camptothecin versus 10-hydroxycamptothecin. Chin. J. Cancer. 10: 198-202